Cardiovascular Research · 2008 · 114 citations · 41 references
MedicineCardiologyPhysiologyBiochemical PharmacologyElectrophysiologyIon Channel BiophysicsAtrial ElectrophysiologyAtrial FibrillationCardiac Ion ChannelsCardiac PhysiologyMembrane ElectrophysiologyMembrane ExcitabilityDelayed Rectifier Potassium CurrentsDocosahexaenoic AcidFatty AcidsTransient Outward Potassium CurrentVoltage-clamp TechniquesVoltage-dependent Channel ActivationVoltage-gated Sodium Channel ModulationVoltage-gated Sodium Channels
AIMS: The omega-3 (n-3) polyunsaturated fatty acids (omega-3 PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from fish oil were recently reported to have an anti-atrial fibrillation effect in humans; however, the ionic mechanisms of this effect are not fully understood. The present study was designed to determine the effects of EPA and DHA on transient outward and ultra-rapid delayed rectifier potassium currents (I(to) and I(Kur)) and the voltage-gated sodium current (I(Na)) in human atrial myocytes. METHODS AND RESULTS: A whole-cell patch voltage clamp technique was employed to record I(to) and I(Kur), and I(Na) in human atrial myocytes. It was found that EPA and DHA inhibited I(to) in a concentration-dependent manner (IC(50): 6.2 microM for EPA; 4.1 microM for DHA) and positively shifted voltage-dependent activation of the current. In addition, I(Kur) was suppressed by 1-50 microM EPA (IC(50): 17.5 microM) and DHA (IC(50): 4.3 microM). Moreover, EPA and DHA reduced I(Na) in human atrial myocytes in a concentration-dependent manner (IC(50): 10.8 microM for EPA; 41.2 microM for DHA) and negatively shifted the potential of I(Na) availability. The I(Na) block by EPA or DHA was use-independent. CONCLUSION: The present study demonstrates for the first time that EPA and DHA inhibit human atrial I(to), I(Kur), and I(Na) in a concentration-dependent manner; these effects may contribute, at least in part, to the anti-atrial fibrillation of omega-3 PUFAs in humans.
41
Prevalence of Diagnosed Atrial Fibrillation in Adults
Alan S. Go, Elaine M. Hylek, Kathleen A. Phillips et al. · JAMA · 2001 · 6.2K citations
Lifetime Risk for Development of Atrial Fibrillation
Donald M. Lloyd‐Jones, Thomas J. Wang, Eric Leip et al. · Circulation · 2004 · 2K citations
Medicine, Cardiology, Aging +16
Ionic mechanisms of electrical remodeling in human atrial fibrillation
Ralph Bosch · Cardiovascular Research · 1999 · 581 citations · Full text
Medicine, Cardiology, Physiology +17